Angiotensin Receptor Blockers and Cancer - UKidney.com
Links shared publicly online about this topic.
- 1,077total visits
Angiotensin Receptor Blockers and Cancer - UKidney.com
View full resource at ukidney.com
Tags: Cancer
Most Recently Shared on June 21, 2010 at 6:31 pm By:
KG likes UKidney's opinion on hot button ARB's and cancer.http://www.ukidney.com/nephrology-blog/angiotensin-receptor-blockers-and-cancer
Effect of Combination Therapy with the Angiotensin Receptor Blocker Losartan plus Hydrochlorothiazide on Brain Perfusion in Patients with both Hypertension and Cerebral Hemodynamic Impairment due to Symptomatic Chronic Major Cerebral Artery Steno-Occlusiv
content.karger.com — “Effect of Combination Therapy with the Angiotensin Receptor Blocker Losartan plus Hydrochlorothiazide on Brain Perfusion in Patients with both Hypertension and Cerebral Hemodynamic Impairment due to Symptomatic Chronic Major Cerebral Artery Steno-Occlusive Disease: A SPECT Study” View full resource at content.karger.com
Most Recently Shared on March 13, 2012 at 9:53 pm By:
Effect of Combination Therapy with the Angiotensin Receptor Blocker Losartan plus Hydrochlorothiazide on Brain P... http://t.co/BWLZSPLM
FDA approves drug combo to treat hypertension
nephrologynews.com — “The drug is a fixed-dose therapy that combimes an angiotensin II receptor blocker (ARB) with the diuretic chlorthalidone in a once-daily, single tablet.” View full resource at nephrologynews.com
Most Recently Shared on December 28, 2011 at 4:22 pm By:
Nephrology News Nephrology and Health News
FDA approves drug combo to treat hypertension http://t.co/qqCthKan
Elsevier
internationaljournalofcardiology.com — “Elsevier” View full resource at internationaljournalofcardiology.com
Most Recently Shared on November 23, 2011 at 3:39 pm By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Poorer control of #hypertension appears to be a common denominator of both new-onset #diabetes and #stroke http://t.co/YajhkZgt
Endocrinology Article | Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials
mdlinx.com — “Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials” View full resource at mdlinx.com
Most Recently Shared on November 10, 2011 at 3:59 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive a... http://t.co/ZxGL2mHn #endo
Double duty for blood pressure drugs: how they could revolutionize how we treat valve disease
eurekalert.org — “A type of medication known as angiotensin-receptor blockers could reduce risk of mortality in people with a heart disease called calcific aortic stenosis (AS) by 30 per cent over an eight-year period, Heart and Stroke Foundation researcher Dr. Philippe Pibarot told delegates at the Canadian Cardiovascular Congress. The condition is currently managed with open heart surgery.” View full resource at eurekalert.org
Most Recently Shared on October 25, 2011 at 5:23 am By:
Double duty for blood pressure drugs: how they could revolutionize how we treat valve disease: ( Heart and Strok... http://t.co/uvj0fZ3u
Fuel to the Fire or Flame Retardant? More on ARB Use/Cancer - QualityPoint Technologies
qualitypointtech.net — “The use of angiotensin-receptor blockers or ACE inhibitors is not associated with a significantly increased risk of cancer, according to a new meta-analysis. The findings add yet another twist to the debate over whether or not the antihypertensive medications are associated with increased cancer incidence. Heartwire” View full resource at qualitypointtech.net
Most Recently Shared on October 6, 2011 at 11:45 pm By:
Fuel to the Fire or Flame Retardant? More on ARB Use/Cancer: The use of angiotensin-receptor blockers or ACE inhib... http://t.co/As4VXumk
Risk documentation occured in only 20% of women age 15-45 prescribed a medication known to contribute to birth defects. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Teratogen use in women of childbearing potential: an intervention study.” View full resource at greenmedinfo.com
Most Recently Shared on August 28, 2011 at 10:31 am By:
Blocking Receptor In Key Hormone Fires Up Enzyme To Kill Pancreatic Cancer Cells - Health News - redOrbit
redorbit.com — “Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.” View full resource at redorbit.com
Most Recently Shared on August 12, 2011 at 5:04 am By:
Endocrinology Wisdom OW Health
Blocking Receptor In Key Hormone Fires Up Enzyme To Kill Pancreatic Cancer Cells: Thomas Jefferson University re... http://bit.ly/npf7se
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells
labspaces.net — “Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.” View full resource at labspaces.net
Most Recently Shared on August 11, 2011 at 1:30 pm By:
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells - http://is.gd/GKtFaS
Blocking Receptor In Key Hormone Fires Up Enzyme To Kill Pancreatic Cancer Cells
medicalnewstoday.com — “Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell gro” View full resource at medicalnewstoday.com
Most Recently Shared on August 11, 2011 at 8:05 am By:
MNT Pancreatic Can Health News
Blocking Receptor In Key Hormone Fires Up Enzyme To Kill Pancreatic Cancer Cells http://mnt.to/3YSp #pancreaticcancer
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells
sciencedaily.com — “Pancreatic cancer researchers have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.” View full resource at sciencedaily.com
Most Recently Shared on August 11, 2011 at 4:54 am By:
Endocrinology Wisdom OW Health
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells: Pancreatic cancer researchers ... http://bit.ly/pA9AhR
Blocking Receptor in Key Hormone Fires Up Enzyme to Kill Pancreatic Cancer Cells
newswise.com — “Thomas Jefferson University research suggests a potential target—Angiotensin II type 2 receptor—for chemopreventive agents to fight pancreatic cancer.” View full resource at newswise.com
Most Recently Shared on August 10, 2011 at 10:52 pm By:
Endocrinology Wisdom OW Health
Blocking Receptor in Key Hormone Fires Up Enzyme to Kill Pancreatic Cancer Cells: Thomas Jefferson University re... http://bit.ly/n4qvuw
Internal Medicine - Cardiology Article | Hypertension
mdlinx.com — “Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups” View full resource at mdlinx.com
Most Recently Shared on August 3, 2011 at 5:24 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Internal Medicine - Cardiology Article | Hypertension http://bit.ly/qah0FK #Health #medicine
Internal Medicine Article | Hypertension
mdlinx.com — “Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups” View full resource at mdlinx.com
Most Recently Shared on August 3, 2011 at 5:17 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Internal Medicine Article | Hypertension http://bit.ly/osqr4F #Health #Medicine
Angiotensin receptor blockers and risk of myocardi... [BMJ. 2011] - PubMed result
instapaper.com — “Angiotensin receptor blockers and risk of myocardi... [BMJ. 2011] - PubMed result” View full resource at instapaper.com
Most Recently Shared on July 17, 2011 at 11:17 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Angiotensin receptor blockers reduce the risk of stroke, heart failure, and new onset diabetes, NO increase risk of MI http://t.co/crNVQp3
Advertisement
